E
RETA

Ergoteles’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Ergoteles’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$624K Buy
2022
Q4 		– Sell
2022
Q3 		$286K Buy
2022
Q1 		– Sell
2021
Q4 		$1.21M Buy
2020
Q4 		– Sell
2020
Q3 		$2.75M Buy